These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 18092426

  • 21. [Inhalation of beta-2 agonists or corticosteroids as single drugs in comparison with combination therapy of patients with COPD].
    Steurer-Stey C.
    Praxis (Bern 1994); 2003 Jul 30; 92(31-32):1324-5. PubMed ID: 12934343
    [No Abstract] [Full Text] [Related]

  • 22. Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease.
    Akazawa M, Hayflinger DC, Stanford RH, Blanchette CM.
    Am J Manag Care; 2008 Jul 30; 14(7):438-48. PubMed ID: 18611095
    [Abstract] [Full Text] [Related]

  • 23. Prevention of death in COPD.
    La Vecchia C, Fabbri LM.
    N Engl J Med; 2007 May 24; 356(21):2211-2; author reply 2213-4. PubMed ID: 17526088
    [No Abstract] [Full Text] [Related]

  • 24. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E, Lazarus SC.
    J Allergy Clin Immunol; 2009 Nov 24; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [Abstract] [Full Text] [Related]

  • 25. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L.
    Am J Geriatr Pharmacother; 2008 Aug 24; 6(3):138-46. PubMed ID: 18775388
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study.
    Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT, Yates JC, Willits LR, Vestbo J.
    Respir Res; 2009 Jun 30; 10(1):59. PubMed ID: 19566934
    [Abstract] [Full Text] [Related]

  • 27. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF.
    Ned Tijdschr Geneeskd; 2007 Oct 06; 151(40):2195-7. PubMed ID: 17969568
    [Abstract] [Full Text] [Related]

  • 28. Summaries for patients. Combination inhaler therapy for chronic obstructive pulmonary disease.
    Ann Intern Med; 2007 Apr 17; 146(8):I12. PubMed ID: 17310044
    [No Abstract] [Full Text] [Related]

  • 29. Safety of inhaled corticosteroids in chronic obstructive pulmonary disease (COPD).
    Med Lett Drugs Ther; 2010 May 31; 52(1339):41-2. PubMed ID: 20508579
    [No Abstract] [Full Text] [Related]

  • 30. Prevention of death in COPD.
    Barnes PJ.
    N Engl J Med; 2007 May 24; 356(21):2211; author reply 2213-4. PubMed ID: 17522406
    [No Abstract] [Full Text] [Related]

  • 31. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R, Make B.
    COPD; 2008 Aug 24; 5(4):221-7. PubMed ID: 18671147
    [Abstract] [Full Text] [Related]

  • 32. [Chronic obstructive pulmonary disease. No increased survival with combination therapy].
    Ecker-Schlipf B.
    Med Monatsschr Pharm; 2007 Nov 24; 30(11):428-9. PubMed ID: 18062342
    [No Abstract] [Full Text] [Related]

  • 33. Treatment of chronic obstructive pulmonary disease: Combination or component therapy?
    Hackam DG.
    CMAJ; 2003 May 13; 168(10):1296-7. PubMed ID: 12743078
    [No Abstract] [Full Text] [Related]

  • 34. Does low-dose seretide reverse chronic obstructive pulmonary disease and are the benefits sustained over time? An open-label Swedish crossover cohort study between 1999 and 2005.
    Rustscheff S, Rydén L.
    J Asthma; 2010 Mar 13; 47(2):214-6. PubMed ID: 20170332
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.
    Singh D, Brooks J, Hagan G, Cahn A, O'Connor BJ.
    Thorax; 2008 Jul 13; 63(7):592-8. PubMed ID: 18245142
    [Abstract] [Full Text] [Related]

  • 37. [New studies refute steroid opponents. COPD--after all a case for corticosteroids?].
    Calverley P.
    MMW Fortschr Med; 2003 Jun 12; 145(24):20. PubMed ID: 12866294
    [No Abstract] [Full Text] [Related]

  • 38. Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators.
    Mapel D, Schum M, Yood M, Brown J, Miller D, Davis K.
    Prim Care Respir J; 2010 Jun 12; 19(2):109-17. PubMed ID: 20082059
    [Abstract] [Full Text] [Related]

  • 39. [Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease].
    Vestbo J.
    Ugeskr Laeger; 2004 Jan 19; 166(4):271-4. PubMed ID: 14964108
    [No Abstract] [Full Text] [Related]

  • 40. Is salmeterol/fluticasone propionate equivalent to tiotropium bromide in the treatment of COPD?
    Gillissen A.
    Am J Respir Crit Care Med; 2008 Jul 01; 178(1):105; author reply 106-7. PubMed ID: 18565963
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.